Loading company…
NovaResp develops software for respiratory monitoring and therapy.
Founded in 2016 and based in Nova Scotia, Canada, NovaResp develops healthcare technology. Its cMAP™ software uses machine learning to support respiratory monitoring and therapy in CPAP machines and help prevent respiratory failure in people with sleep apnea and other respiratory diseases. In January 2023, it received USD 0.25 million in grant funding from the Atlantic Canada Opportunities Agency and raised USD 2 million in Seed funding led by Concrete Ventures and Invest Nova Scotia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in